63. 特発性血小板減少性紫斑病 ［臨床試験数：311，薬物数：185（DrugBank：39），標的遺伝子数：43，標的パスウェイ数：132］
Searched query = "Idiopathic thrombocytopenic purpura", "Primary immune thrombocytopenia"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
|1||EUCTR2019-004683-22-NO||16/10/2020||29/04/2020||Daratumumab as a treatment for adult immune thrombocytopenia||Daratumumab as a treatment for adult immune thrombocytopenia - The DART-study||Immune thrombocytopenia |
MedDRA version: 23.0Level: LLTClassification code 10021245Term: Idiopathic thrombocytopenic purpuraSystem Organ Class: 100000004851;Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]
|Product Name: daratumumab|
INN or Proposed INN: DARATUMUMAB
Other descriptive name: HUMAX-CD38
|Ostfold Hospital Trust||NULL||Authorised-recruitment may be ongoing or finished||Female: yes|